Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

3,736 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Circulating Tumor DNA Dynamics Predict Benefit from Consolidation Immunotherapy in Locally Advanced Non-Small Cell Lung Cancer.
Moding EJ, Liu Y, Nabet BY, Chabon JJ, Chaudhuri AA, Hui AB, Bonilla RF, Ko RB, Yoo CH, Gojenola L, Jones CD, He J, Qiao Y, Xu T, Heymach JV, Tsao A, Liao Z, Gomez DR, Das M, Padda SK, Ramchandran KJ, Neal JW, Wakelee HA, Loo BW Jr, Lin SH, Alizadeh AA, Diehn M. Moding EJ, et al. Among authors: das m. Nat Cancer. 2020 Feb;1(2):176-183. doi: 10.1038/s43018-019-0011-0. Epub 2020 Jan 20. Nat Cancer. 2020. PMID: 34505064 Free PMC article.
Vascular disrupting agents.
Das M, Wakelee H. Das M, et al. J Thorac Oncol. 2010 Dec;5(12 Suppl 6):S482-3. doi: 10.1097/01.JTO.0000391376.09556.d8. J Thorac Oncol. 2010. PMID: 21102249 Free article. No abstract available.
Results from a single institution phase II trial of concurrent docetaxel/carboplatin/radiotherapy followed by surgical resection and consolidation docetaxel/carboplatin in stage III non-small-cell lung cancer.
Das M, Donington JS, Murphy J, Kozak M, Eclov N, Whyte RI, Hoang CD, Zhou L, Le QT, Loo BW, Wakelee H. Das M, et al. Clin Lung Cancer. 2011 Sep;12(5):280-5. doi: 10.1016/j.cllc.2011.06.003. Epub 2011 Jul 14. Clin Lung Cancer. 2011. PMID: 21752720 Clinical Trial.
Angiogenesis inhibitors.
Das M, Wakelee H. Das M, et al. J Thorac Oncol. 2011 Nov;6(11 Suppl 4):S1801-2. doi: 10.1097/01.JTO.0000407564.91781.ab. J Thorac Oncol. 2011. PMID: 22005536 Free article. No abstract available.
Targeting VEGF in lung cancer.
Das M, Wakelee H. Das M, et al. Expert Opin Ther Targets. 2012 Apr;16(4):395-406. doi: 10.1517/14728222.2012.669752. Epub 2012 Mar 23. Expert Opin Ther Targets. 2012. PMID: 22439677 Review.
ERCC1 expression in circulating tumor cells (CTCs) using a novel detection platform correlates with progression-free survival (PFS) in patients with metastatic non-small-cell lung cancer (NSCLC) receiving platinum chemotherapy.
Das M, Riess JW, Frankel P, Schwartz E, Bennis R, Hsieh HB, Liu X, Ly JC, Zhou L, Nieva JJ, Wakelee HA, Bruce RH. Das M, et al. Lung Cancer. 2012 Aug;77(2):421-6. doi: 10.1016/j.lungcan.2012.04.005. Epub 2012 May 1. Lung Cancer. 2012. PMID: 22555222
Angiogenesis inhibitors.
Das M, Wakelee H. Das M, et al. J Thorac Oncol. 2012 Dec;7(16 Suppl 5):S397-8. doi: 10.1097/JTO.0b013e31826df227. J Thorac Oncol. 2012. PMID: 23160332 Free article. Review. No abstract available.
3,736 results